PEAR - Pear Therapeutics GAAP EPS of $0.04 beats by $0.29 revenue of $3.3M misses by $0.94M August, 11 2022 04:48 PM Pear Therapeutics Inc. Pear Therapeutics press release ( NASDAQ: PEAR ): Q2 GAAP EPS of $0.04 beats by $0.29 . Revenue of $3.3M (+175.0% Y/Y) misses by $0.94M . Shares -0.44% . For further details see: Pear Therapeutics GAAP EPS of $0.04 beats by $0.29, revenue of $3.3M misses by $0.94M